https://www.mobihealthnews.com/news/abbott-app-replacing-neuromodulation-system-controllers-receives-fda-approval

Abbott has received FDA approval for a neuromodulation system-controller app that runs on iOS devices, the company announced Thursday.

Compatible with Abbott’s broader NeuroSphere Digital Care platform, the Patient Controller app replaces the separate device patients use to adjust the company’s neuromodulation products. These include the Infinity DBS System for Parkinson’s disease or essential tremor,